Enhanced Healing and Outcomes With Human Dermal Fibroblast Exosomes: Case Series Combining Deep Helium Radiofrequency Plasma Skin Resurfacing, Facelifts, and Exosomes.

Aesthetic surgery journal 2026 Vol.46(Supplement_1) p. S73-S81

Lacerna Kimbrell M

관련 도메인

Abstract

[BACKGROUND] Deep skin resurfacing with helium radiofrequency plasma produces rhytid and photodamage correction with significant tissue contraction. Although the outcomes can be quite impressive, the recovery process can be daunting and prolonged.

[OBJECTIVES] The aim of this study was to demonstrate that topical application of human dermal fibroblast exosomes after deep skin resurfacing can significantly decrease the number of days to achieve re-epithelialization.

[METHODS] This study presents a retrospective review (July 2017-September 2025) of 101 patients. The patients were divided into 4 groups: Group 1 (n = 18, resurfacing only, no exosomes, age 36-75 years), Group 2 (n = 27, resurfacing only plus exosomes, age 30-82 years), Group 3 (n = 23, resurfacing plus facelift, no exosomes, age 50-80 years), and Group 4 (n = 33, resurfacing plus facelift, plus exosomes, age 54-77 years). The number of days to full re-epithelialization was compared between groups.

[RESULTS] For the resurfacing-only patients, days to re-epithelialization for Group 1 (no exosomes) ranged from 10 to 21 (median, 15.5; mean [standard deviation], 15.78 [3.26]), compared with Group 2 (exosome treated), which ranged from 6 to 16 days (median, 10; mean, 10.74 [2.50]) (P < .0001 and t-statistic = 5.54). For the resurfacing plus facelift patients, days to re-epithelialization for Group 3 (no exosomes) ranged from 9 to 21 (median, 15; mean, 15.48 [3.58]), compared with Group 4 (exosome treated), which ranged from 7 to 14 days (median, 10.5; mean 10.24 [2.24]) (P < .0001 and t-statistic = 6.22). The rates of complications were: Group 1, 3 of 18 patients (16.67%); Group 3, 3 of 23 patients (13.04%); Group 2, 0 patients; and Group 4, 1 of 33 patients (3.03%).

[CONCLUSIONS] This 8-year series with 101 patients demonstrates that the application of topical exosomes decreased the days to re-epithelialization and the complication rates, highlighting their promising role in accelerated healing following deep skin resurfacing procedures.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 facelift 안면거상술 dict 3
해부 Exosomes scispacy 1
해부 tissue scispacy 1
해부 skin scispacy 1
해부 exosome scispacy 1
약물 Helium C0018880
helium
scispacy 1
약물 [BACKGROUND] Deep skin resurfacing with helium radiofrequency plasma produces rhytid and scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [3.26] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Case scispacy 1
기타 Human Dermal Fibroblast Exosomes scispacy 1
기타 Plasma Skin scispacy 1
기타 Facelifts scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Middle Aged; Aged; Exosomes; Female; Retrospective Studies; Adult; Fibroblasts; Male; Skin Aging; Re-Epithelialization; Aged, 80 and over; Treatment Outcome; Rhytidoplasty; Helium; Wound Healing

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문